Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs

Author： de Smit A.J.   Bouma A.   van Gennip H.G.P.   de Kluijver E.P.   Moormann R.J.M.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.19, Iss.11, 2001-12, pp. : 1467-1476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chimeric classical swine fever viruses containing envelope protein E RNS or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response

By van Gennip  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 447-459

Elsevier

Access to resources Recommend Favorite

An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV)

By van Rijn P.A.   van Gennip H.G.P.   Moormann R.J.M.  

Vaccine, Vol. 17, Iss. 5, 1999-02 ,pp. : 433-440

Elsevier

Access to resources Recommend Favorite

Recombinant classical swine fever (CSF) viruses derived from the Chinese vaccine strain (C-strain) of CSF virus retain their avirulent and immunogenic characteristics

By de Smit A.J.   van Gennip H.G.P.   Miedema G.K.W.   van Rijn P.A.   Terpstra C.   Moormann R.J.M.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2351-2358

Elsevier

Access to resources Recommend Favorite

Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E rns or E2 of CSFV

By van Gennip H.G.P.   Bouma A.   van Rijn P.A.   Widjojoatmodjo M.N.   Moormann R.J.M.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1544-1556

Elsevier

Access to resources Recommend Favorite

Influence of maternal antibodies on efficacy of a subunit vaccine: transmission of classical swine fever virus between pigs vaccinated at 2 weeks of age

By Klinkenberg D.   Moormann R.J.M.   de Smit A.J.   Bouma A.   de Jong M.C.M.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 3005-3013

Elsevier

Access to resources Recommend Favorite